Table 2.
Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Proportion (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICU stay (d) | 7 | 50 | 11 | 21 | 6 | 3 | 5 | 1 | 10 | 8 | 21 | 10 | NA |
Mechanical ventilation | |||||||||||||
Duration (d) | 4 | 48 | 7 | 19 | 6 | 1 | 4 | 1 | 9 | 5 | 21 | 8 | NA |
ECMO (d) | – | 18 | – | – | – | – | – | – | – | – | 12 | – | NA |
Medication | |||||||||||||
Antibiotics | + | + | + | + | + | + | + | + | + | + | + | + | 12/12(100) |
Antivirals | + | + | + | – | – | – | + | – | – | + | + | + | 7/12(58) |
Anti-TB | – | – | + | – | + | – | – | – | – | – | – | + | 2/12(17) |
GC | + | + | + | + | + | – | – | – | + | + | – | + | 8/12(67) |
IVIG | – | + | – | – | – | – | – | – | – | + | + | + | 4/12(33) |
ICU intensive care unit, ECMO extracorporeal membrane oxygenation, TB tuberculosis, GC, glucocorticoids, IVIG intravenous immunoglobin